Jyong Biotech MENS
NASDAQ MENS
$1.74 -0.05 (-2.79%)
At close: Nov 11, 2026 · 4:00 PM EST

Jyong Biotech (MENS) Cash & Equivalents (2024 - 2025)

Updated

Jyong Biotech's Cash & Equivalents came in at $1.18 million for the quarter ended Dec 31, 2025, compared with $98,000 a year earlier.

Analysis

Jyong Biotech (MENS) Cash & Equivalents (2024 - 2025) Analysis & Trends

  • Going back by year, Cash & Equivalents was $98,000 in the year ended Dec 31, 2024 (-95.7%) and $2.27 million in the year ended Dec 31, 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 4.89 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 16.91 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 10.77 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 9.55 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - 400.00 Mn
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 7.94 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 13.19 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 6.44 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 1.82 Bn
10 Jyong Biotech 136.09 Mn 134.91 Mn - 1.18 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 1.18 Mn
Jun 30, 2025 132,000.00
Dec 31, 2024 101,000.00
API Access

Jyong Biotech Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=MENS&period=max&api_key=YOUR_API_KEY